SAUNDERS BRENT L — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

SAUNDERS BRENT L has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $500K. Lifetime open-market sales: $1.71M.

Profile

SAUNDERS BRENT L

Brent L. Saunders is a prominent executive known for his leadership roles in the healthcare and pharmaceutical industries. He is currently the CEO and Chairman of the Board at Bausch & Lomb Corp, and has previously held significant positions at other companies including Allergan and Bausch Health.

RoleInsider
Notability30/100
LinksWikipedia

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-26BLCOBausch & Lomb CorpF — Tax withholding / forfeiture2.9K$15.92$46K
2026-03-10BLCOBausch & Lomb CorpA — Grant or award14.7K$0.00
2026-03-10BLCOBausch & Lomb CorpP — Open-market purchase14.7K$17.14$252K
2026-03-02BLCOBausch & Lomb CorpF — Tax withholding / forfeiture24.6K$18.30$451K
2026-03-02BLCOBausch & Lomb CorpF — Tax withholding / forfeiture22.1K$18.49$408K
2026-02-27BLCOBausch & Lomb CorpA — Grant or award327.1K$0.00
2026-02-25BLCOBausch & Lomb CorpF — Tax withholding / forfeiture65.4K$17.99$1.18M
2025-08-05BLCOBausch & Lomb CorpF — Tax withholding / forfeiture4.2K$14.44$61K
2025-06-16SKINBeauty Health CoA — Grant or award73.1K
2025-05-22BLCOBausch & Lomb CorpA — Grant or award22.0K$0.00
2025-05-22BLCOBausch & Lomb CorpP — Open-market purchase22.0K$11.28$248K
2025-05-20SPRYARS Pharmaceuticals, Inc.S — Open-market sale120.0K$14.25$1.71M
2025-05-20SPRYARS Pharmaceuticals, Inc.M — Option exercise120.0K$1.01$121K
2024-12-26BLCOBausch & Lomb CorpF — Tax withholding / forfeiture24.6K$17.83$439K
2024-12-26BLCOBausch & Lomb CorpF — Tax withholding / forfeiture73.8K$17.83$1.32M

Companies — Last 90 Days

Frequently Asked Questions

Who is SAUNDERS BRENT L?

Brent L. Saunders is a prominent executive known for his leadership roles in the healthcare and pharmaceutical industries. He is currently the CEO and Chairman of the Board at Bausch & Lomb Corp, and has previously held significant positions at other companies including Allergan and Bausch Health.…

How many SEC Form 4 filings has SAUNDERS BRENT L submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Has SAUNDERS BRENT L been buying or selling stock?

Recorded transactions: 2 open-market purchases ($500K) and 1 open-market sales ($1.71M) across all tracked filings.

Where can I see all of SAUNDERS BRENT L's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live SAUNDERS BRENT L profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.